|
Jun 26
|
Lilly joins fellow pharma giants in OpenAI partnership
|
|
Jun 26
|
The S&P 500 and Nvidia, Chipotle stock split: Morning Brief
|
|
Jun 26
|
Yahoo Video: Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst
|
|
Jun 26
|
Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst
|
|
Jun 26
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
|
Jun 26
|
La-Z-Boy and Winnebago have been highlighted as Zacks Bull and Bear of the Day
|
|
Jun 26
|
The War Over Cheaper Ozempic Won’t End Well for Some Investors
|
|
Jun 26
|
2 Reasons Why Eli Lilly's Stock Likely Hasn't Peaked
|
|
Jun 25
|
Why Drugmaker Eli Lilly Is Partnering With ChatGPT Maker OpenAI
|
|
Jun 25
|
AI Work Assistants Need a Lot of Handholding
|
|
Jun 25
|
Insulet Points Its Insulin Pump at the Big Diabetes Market: Type 2
|
|
Jun 25
|
Novo Nordisk (NVO) to Invest $4.1B in Clayton Facility Expansion
|
|
Jun 25
|
Novo Nordisk Rises as Wegovy Is Approved in China
|
|
Jun 25
|
From Sci-Fi Dream to Market Maze: Eli Lilly's Weight-Loss Medication Faces Hurdles
|
|
Jun 25
|
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria
|
|
Jun 25
|
Is Eli Lilly (LLY) a Buy on Tirzepatide Success in Sleep Apnea?
|
|
Jun 25
|
Novo to spend $4B on US plant, adding to obesity drug production push
|
|
Jun 14
|
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
|
|
Jun 14
|
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
|
|
Jun 14
|
Zacks Market Edge Highlights: CAVA, Abercrombie & Fitch, Eli Lilly, CrowdStrike and Deckers Outdoor
|